服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-TIGIT/WUCAM/VSTM3 mAbs [Tamgiblimab Biosimilar] (MABL-5282) | MABL-5282 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-DPEP3 mAbs [Tamrintamab Biosimilar] (MABL-5283) | MABL-5283 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD52 mAbs [Tamtuvetmab Biosimilar] (MABL-5284) | MABL-5284 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-NGFB mAbs [Tanezumab Biosimilar] (MABL-5285) | MABL-5285 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-C1q mAbs [Tanruprubart Biosimilar] (MABL-5286) | MABL-5286 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VEGFA mAbs [Tarcocimab Biosimilar] (MABL-5287) | MABL-5287 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NOTCH2 and NOTCH3 mAbs [Tarextumab Biosimilar] (MABL-5288) | MABL-5288 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-DLL3;CD3E mAbs [Tarlatamab Biosimilar] (MABL-5289) | MABL-5289 | ELISA, FACS, Functional assay, in vivo binding | na;na, Kappa;Lambda |
| Anti-ALB;CFP mAbs [Tarperprumig Biosimilar] (MABL-5290) | MABL-5290 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-TNFSF4/CD134/CD252/OX40L mAbs [Tavolimab Biosimilar] (MABL-5291) | MABL-5291 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CTLA4/CD152 mAbs [Tazlestobart Biosimilar] (MABL-5292) | MABL-5292 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3E mAbs [Tebentafusp Biosimilar] (MABL-5293) | MABL-5293 | ELISA, FACS, Functional assay, in vivo binding | na, Kappa |
| Anti-Respiratory Syncytial Virus Glycoprotein F mAbs [Suptavumab Biosimilar] (MABL-5262) | MABL-5262 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD3D&CD3E;CD19 mAbs [Surovatamig Biosimilar] (MABL-5263) | MABL-5263 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;na |
| Anti-HAVCR2/TIM3 mAbs [Surzebiclimab Biosimilar] (MABL-5264) | MABL-5264 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F7a/F7A/FVIIa/FVIIA;TREML1/GLTL1825/PRO3438/TLT-1/TLT1 mAbs [Sutacimig Biosimilar] (MABL-5265) | MABL-5265 | ELISA, FACS, Functional assay, in vivo binding | G4;G4, Kappa;Kappa |
| Anti-C1S mAbs [Sutimlimab Biosimilar] (MABL-5266) | MABL-5266 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-VEGFA mAbs [Suvemcitug Biosimilar] (MABL-5267) | MABL-5267 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-HIV-1 gp120 mAbs [Suvizumab Biosimilar] (MABL-5268) | MABL-5268 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD24 mAbs [Suvonstobart Biosimilar] (MABL-5269) | MABL-5269 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn